van Helden HP - Search Results

1

Percutaneous exposure to VX: clinical signs, effects on brain acetylcholine levels and EEG.

Joosen MJ, van der Schans MJ, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Neurochem Res. 2008 Feb;33(2):308-17. doi: 10.1007/s11064-007-9508-5. Epub 2007 Oct 17. Neurochem Res. 2008. PMID: 17940880

2

Correlations between acetylcholinesterase inhibition, acetylcholine levels and EEG changes during perfusion with neostigmine and N6-cyclopentyladenosine in rat brain.

Joosen MJ, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Eur J Pharmacol. 2007 Jan 26;555(2-3):122-8. doi: 10.1016/j.ejphar.2006.10.006. Epub 2006 Oct 17. Eur J Pharmacol. 2007. PMID: 17113068

3

Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment.

Joosen MJ, van der Schans MJ, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Chem Biol Interact. 2010 Oct 6;188(1):255-63. doi: 10.1016/j.cbi.2010.06.010. Epub 2010 Jun 23. Chem Biol Interact. 2010. PMID: 20599844

4

Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.

Joosen MJ, van der Schans MJ, Kuijpers WC, van Helden HP, Noort D. Joosen MJ, et al. Among authors: van helden hp. Chem Biol Interact. 2013 Mar 25;203(1):149-53. doi: 10.1016/j.cbi.2012.10.002. Epub 2012 Oct 16. Chem Biol Interact. 2013. PMID: 23085122 Review.

5

Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.

Bueters TJ, Joosen MJ, van Helden HP, Ijzerman AP, Danhof M. Bueters TJ, et al. Among authors: van helden hp. J Pharmacol Exp Ther. 2003 Mar;304(3):1307-13. doi: 10.1124/jpet.102.044644. J Pharmacol Exp Ther. 2003. PMID: 12604711

6

Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning.

Joosen MJ, Bueters TJ, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Arch Toxicol. 2004 Jan;78(1):34-9. doi: 10.1007/s00204-003-0513-4. Epub 2003 Sep 24. Arch Toxicol. 2004. PMID: 14508639

7

Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning.

Joosen MJ, Jousma E, van den Boom TM, Kuijpers WC, Smit AB, Lucassen PJ, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Neurotoxicology. 2009 Jan;30(1):72-80. doi: 10.1016/j.neuro.2008.11.010. Epub 2008 Nov 28. Neurotoxicology. 2009. PMID: 19100287

8

Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?

Joosen MJ, Smit AB, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Arch Toxicol. 2011 Mar;85(3):227-37. doi: 10.1007/s00204-010-0571-3. Epub 2010 Sep 15. Arch Toxicol. 2011. PMID: 20842348 Free PMC article.

9

Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.

van Helden HP, Joosen MJ, Philippens IH. van Helden HP, et al. Toxicol Lett. 2011 Sep 25;206(1):35-40. doi: 10.1016/j.toxlet.2011.04.021. Epub 2011 Apr 28. Toxicol Lett. 2011. PMID: 21554933 Review.

10

Increasing oxime efficacy by blood-brain barrier modulation.

Joosen MJ, van der Schans MJ, van Dijk CG, Kuijpers WC, Wortelboer HM, van Helden HP. Joosen MJ, et al. Among authors: van helden hp. Toxicol Lett. 2011 Sep 25;206(1):67-71. doi: 10.1016/j.toxlet.2011.05.231. Epub 2011 May 11. Toxicol Lett. 2011. PMID: 21600273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page